sureprint g3 human mirna microarray kit (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
sureprint g3 human mirna microarray kit
Sureprint G3 Human Mirna Microarray Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureprint+g3+human+mirna+microarray/pmc11215600-35-9-15
Average 90 stars, based on 1 article reviews
Sureprint G3 Human Mirna Microarray Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureprint+g3+human+mirna+microarray/pmc11215600-35-9-15
Average 90 stars, based on 1 article reviews
sureprint g3 human mirna microarray kit - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Expressing:Article Title: Cell having ability to form stratified epithelial tissue, and method for producing same Article Snippet: The total RNA was collected from 107 cells of each of the primary cultured skin fibroblasts and the primary cultured keratinocytes, and their mRNA expressions were comprehensively compared with each other using Gene ST 1.0 microarray (Affymetrix, Inc.) (FIG. 3). .. In order to compare the microRNAs expressing the primary cultured fibroblast, and the primary cultured keratinocyte, the primary cultured fibroblast and the primary cultured keratinocyte were separated and cultured from 3 skin specimens of different sites collected from the same donor, the microRNA was collected from 107 cells, and the microRNA expressions were comprehensively compared using Article Title: Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. Article Snippet: .. RNA aliquots from these samples were hybridized on four microarray platforms: Agilent Article Title: Supplementary Materials Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review Article Snippet: .. Summary characteristics of studies of genome-wide miRNA expression measured in breast cancer tissue and risk of recurrence among HER2-positive, trastuzumab- treated breast cancer patients (n = 2) Study design Retrospective studies: n = 2 (Du[10], Ohzawa[11]) Breast cancer patients Number of patients: 14 to 40 Median age: 55 y (Ohzawa[11]), NR in one study (Du[10]) Postmenopausal patients: NR ER-positive breast cancer: NR HR-positive breast cancer: 42.5% to 50% miRNA expression Measurement methods: Agilent miRNA array (n = 1) (Du[10]), Agilent Cell Culture:Article Title: Cell having ability to form stratified epithelial tissue, and method for producing same Article Snippet: The total RNA was collected from 107 cells of each of the primary cultured skin fibroblasts and the primary cultured keratinocytes, and their mRNA expressions were comprehensively compared with each other using Gene ST 1.0 microarray (Affymetrix, Inc.) (FIG. 3). .. In order to compare the microRNAs expressing the primary cultured fibroblast, and the primary cultured keratinocyte, the primary cultured fibroblast and the primary cultured keratinocyte were separated and cultured from 3 skin specimens of different sites collected from the same donor, the microRNA was collected from 107 cells, and the microRNA expressions were comprehensively compared using Microarray:Article Title: Cell having ability to form stratified epithelial tissue, and method for producing same Article Snippet: The total RNA was collected from 107 cells of each of the primary cultured skin fibroblasts and the primary cultured keratinocytes, and their mRNA expressions were comprehensively compared with each other using Gene ST 1.0 microarray (Affymetrix, Inc.) (FIG. 3). .. In order to compare the microRNAs expressing the primary cultured fibroblast, and the primary cultured keratinocyte, the primary cultured fibroblast and the primary cultured keratinocyte were separated and cultured from 3 skin specimens of different sites collected from the same donor, the microRNA was collected from 107 cells, and the microRNA expressions were comprehensively compared using Article Title: Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer Article Snippet: Peak of RNA fragments was located at ~100 nt in length.RNA integrity number of this sample was ... table ft1 table-wrap mode=article t1 Table I. caption a4 Summary of yield and quality of extracted RNA samples. miRNA microarray expression analysis Total RNA (100 ng) was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling and Hyb kit (Agilent Technologies, Inc.). .. Labeled RNA was hybridized to an Agilent Article Title: Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. Article Snippet: .. RNA aliquots from these samples were hybridized on four microarray platforms: Agilent Article Title: Supplementary Materials Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review Article Snippet: .. Summary characteristics of studies of genome-wide miRNA expression measured in breast cancer tissue and risk of recurrence among HER2-positive, trastuzumab- treated breast cancer patients (n = 2) Study design Retrospective studies: n = 2 (Du[10], Ohzawa[11]) Breast cancer patients Number of patients: 14 to 40 Median age: 55 y (Ohzawa[11]), NR in one study (Du[10]) Postmenopausal patients: NR ER-positive breast cancer: NR HR-positive breast cancer: 42.5% to 50% miRNA expression Measurement methods: Agilent miRNA array (n = 1) (Du[10]), Agilent Labeling:Article Title: Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer Article Snippet: Peak of RNA fragments was located at ~100 nt in length.RNA integrity number of this sample was ... table ft1 table-wrap mode=article t1 Table I. caption a4 Summary of yield and quality of extracted RNA samples. miRNA microarray expression analysis Total RNA (100 ng) was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling and Hyb kit (Agilent Technologies, Inc.). .. Labeled RNA was hybridized to an Agilent Hybridization:Article Title: Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer Article Snippet: Peak of RNA fragments was located at ~100 nt in length.RNA integrity number of this sample was ... table ft1 table-wrap mode=article t1 Table I. caption a4 Summary of yield and quality of extracted RNA samples. miRNA microarray expression analysis Total RNA (100 ng) was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling and Hyb kit (Agilent Technologies, Inc.). .. Labeled RNA was hybridized to an Agilent Genome Wide:Article Title: Supplementary Materials Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review Article Snippet: .. Summary characteristics of studies of genome-wide miRNA expression measured in breast cancer tissue and risk of recurrence among HER2-positive, trastuzumab- treated breast cancer patients (n = 2) Study design Retrospective studies: n = 2 (Du[10], Ohzawa[11]) Breast cancer patients Number of patients: 14 to 40 Median age: 55 y (Ohzawa[11]), NR in one study (Du[10]) Postmenopausal patients: NR ER-positive breast cancer: NR HR-positive breast cancer: 42.5% to 50% miRNA expression Measurement methods: Agilent miRNA array (n = 1) (Du[10]), Agilent Formalin-fixed Paraffin-Embedded:Article Title: Supplementary Materials Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review Article Snippet: .. Summary characteristics of studies of genome-wide miRNA expression measured in breast cancer tissue and risk of recurrence among HER2-positive, trastuzumab- treated breast cancer patients (n = 2) Study design Retrospective studies: n = 2 (Du[10], Ohzawa[11]) Breast cancer patients Number of patients: 14 to 40 Median age: 55 y (Ohzawa[11]), NR in one study (Du[10]) Postmenopausal patients: NR ER-positive breast cancer: NR HR-positive breast cancer: 42.5% to 50% miRNA expression Measurement methods: Agilent miRNA array (n = 1) (Du[10]), Agilent |